OCI NV (0QGH)
London Exchange · UK · prices in EUR · close of 23 Oct 2026
Key indicators
| Last close | EUR 4.125 |
|---|---|
| 52-week range | 2.554 – 4.500 |
| Return, 1 month / 3 months | +0.3% / +1.3% |
| Return, 1 year / 3 years | +19.2% / −56.4% |
| Trend | Uptrend |
| RSI (14) | 51 |
| Volatility (1 year) | 69.2% |
| Worst drawdown (1 year) | -24.7% |
| Average daily value traded | 0.16M EUR |
| Dividend yield | – |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
OCI NV is a chemicals and fertilizer producer based in the Netherlands. It makes nitrogen-based fertilizers, including ammonia and urea, for farmers and agricultural distributors, and also produces industrial chemicals such as methanol and melamine for manufacturing customers. The company operates production sites in several countries and supplies both agricultural and industrial markets, with much of its output sold internationally through its own sales network and trading operations.
OCI NV trades under the code 0QGH on the London Exchange in UK, with its price quoted in euros (EUR). Our dividend records, which start in 2019, show payments in 4 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
OCI NV (0QGH) trades on the London Exchange in UK. It last closed at EUR 4.125 on 23 October 2026.
Its price-based Market X-Ray is 58 out of 100 (a fair price profile), ranking 1,498 of 3,787 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 19.2% and over the last three months it rose 1.3%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on London Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 83 · Strong | Trading above its long-term averages and near its highs. | |
| Above 200-day average | 10.6% | ||
| From 52-week high | -1.2% | ||
| Momentum | 68 · Fair | Typical recent returns for this exchange. | |
| 3-month return | 1.3% | ||
| 6-month return | 13.6% | ||
| 12-month return, skipping the last month | 18.8% | ||
| Stability (higher is calmer) | 38 · Weak | Volatile, with deep drawdowns. | |
| Volatility, 1 year (lower is calmer) | 69.2% | ||
| Worst drawdown, 1 year (smaller is calmer) | -24.7% | ||
| Liquidity | 35 · Weak | Thinly traded: prices can jump and exits can be hard. | |
| Average daily value traded | 0.16M EUR | ||
| Zero-volume days | 1.7% | ||
| Income | – | Pays no dividend. | |
| Dividend yield | – | ||
| Years with dividends | 4 |
Strengths
- Trend: Trading above its long-term averages and near its highs.
Weak spots
- Stability (higher is calmer): Volatile, with deep drawdowns.
- Liquidity: Thinly traded: prices can jump and exits can be hard.
Returns
| 1 week | −0.1% |
|---|---|
| 1 month | +0.3% |
| 3 months | +1.3% |
| 6 months | +13.6% |
| 1 year | +19.2% |
| 3 years | −56.4% |
| 5 years | −48.2% |
Signals
| 50-day / 200-day average | 4.098 / 3.731 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 0.252 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 18 Aug 2025 | EUR 2.8377 |
| 15 Apr 2025 | EUR 4.1843 |
| 28 Oct 2024 | EUR 0.1450 |
| 26 Oct 2023 | EUR 0.8500 |
| 20 Apr 2023 | EUR 3.5000 |
| 26 Oct 2022 | EUR 3.5500 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on London Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.